Role of the melanocortin-4 receptor in metabolic rate and food intake in mice

被引:201
|
作者
Chen, AS
Metzger, JM
Trumbauer, ME
Guan, XM
Yu, H
Frazier, EG
Marsh, DJ
Forrest, MJ
Gopal-Truter, S
Fisher, J
Camacho, RE
Strack, AM
Mellin, TN
MacIntyre, DE
Chen, HY
Van der Ploeg, LHT [1 ]
机构
[1] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Anim Pharmacol, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Comparat Med, Rahway, NJ 07065 USA
关键词
food intake; melanocortin-4; receptor; metabolic rate; MT-II;
D O I
10.1023/A:1008983615045
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We evaluated the role of the melanocortin-4 receptor (MC-4R) in the control of metabolic rate and food intake in mice. Intraperitoneal administration of the non-selective MC-R agonist melanotan II (MT-II; a cyclic heptapeptide) increases metabolic rate in wildtype mice, while MC-4R knockout mice are insensitive to the effects of MT-II on metabolic rate. MC-4R knockout mice are also insensitive to the effects of MT-II on reducing food intake. We conclude that MC-4R can mediate control of both metabolic rate and food intake in mice. We infer that a role for MC-3R in mediating the acute effects of MT-II on basal metabolic rate and food intake in wildtype mice seems limited.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 50 条
  • [41] The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist
    Markison, S
    Foster, AC
    Chen, C
    Brookhart, GB
    Hesse, A
    Hoare, SRJ
    Fleck, BA
    Brown, BT
    Marks, DL
    ENDOCRINOLOGY, 2005, 146 (06) : 2766 - 2773
  • [42] Activation of melanocortin-4 receptors stimulates hypothalamic BDNF release to decrease food intake.
    Nicholson, Janet R.
    Peter, Jean-Christophe
    Lecourt, Anne-Catherine
    Matsumoto, T.
    Barde, Yves-Alain
    Hofbauer, Karl G.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S21 - S21
  • [43] Melanocortin-4 receptor and leptin receptor gene variants in Koreans
    Suh, YS
    Lee, IK
    OBESITY RESEARCH, 2003, 11 : A129 - A129
  • [44] Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice
    Clemmensen, Christoffer
    Finan, Brian
    Fischer, Katrin
    Tom, Robby Zachariah
    Legutko, Beata
    Sehrer, Laura
    Heine, Daniela
    Grassl, Niklas
    Meyer, Carola W.
    Henderson, Bart
    Hofmann, Susanna M.
    Tschoep, Matthias H.
    Van der Ploeg, Lex H. T.
    Mueller, Timo D.
    EMBO MOLECULAR MEDICINE, 2015, 7 (03) : 288 - 298
  • [45] Role of Melanocortin-4 Receptor Activation in Hypertension Induced by Chronic Intermittent Hypoxia
    Maok, Sydney P.
    da Silva, Alexandre A.
    Hall, John E.
    do Carmo, Jussara M.
    FASEB JOURNAL, 2018, 32 (01):
  • [46] Melanocortin Pathways: Suppressed and Stimulated Melanocortin-4 Receptor (MC4R)
    Hainer, Vojtech
    Aldhoon Hainerova, Irena
    Kunesova, Marie
    Taxova Braunerova, Radka
    Zamrazilova, Hana
    Bendlova, Bela
    PHYSIOLOGICAL RESEARCH, 2020, 69 : S245 - S254
  • [47] Melanocortin-4 receptor selective small molecules.
    Wu, ZJ
    Rajpurohit, R
    Shi, YQ
    Sharma, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U59 - U60
  • [48] Deficient melanocortin-4 receptor causes abnormal reproductive neuroendocrine profile in female mice
    Chen, Xiaolin
    Huang, Lili
    Tan, Hwee Y.
    Li, Hongzhuo
    Wan, Ying
    Cowley, Michael
    Veldhuis, Johannes D.
    Chen, Chen
    REPRODUCTION, 2017, 153 (03) : 267 - 276
  • [49] Role Of Endogenous Brain Melanocortin-4 Receptor Activation In Regulating Blood Pressure And Metabolic Function In Offspring Of Parents With Obesity
    da Silva, Alexandre A.
    Moak, Sydney
    Dai, Xuemei
    Borges, Gisele
    Omoto, Ana C.
    Gulke, Rodrigo
    Wang, Zhen
    Li, Xuan
    Mouton, Alan J.
    Hall, John E.
    do Carmo, Jussara M.
    HYPERTENSION, 2022, 79
  • [50] Recent advances in the development of melanocortin-4 receptor ligands
    Nozawa, Dai
    Chaki, Shigeyuki
    Nakazato, Atsuro
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (04) : 403 - 427